Parvovirus B19 (Human), IgG/IgM-13537

Test info

  
Parvovirus B19 (Human), IgG/IgM
  
13537
  
LAB13537
  
PARVOB19AB
  
Human Parvovirus B19, IgG, IgM
  

Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection.

Specimen

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
  

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

  
  • Hemolysis
  • Lipemia
  • Gross bacterial contamination

Performance

  
LabCorp Burlington (163303): R-LC
  
Mo - Fr
  
1 - 3 days
  

Enzyme immunoassay (EIA)

Clinical and Interpretive info

  

Negative:

IgG: < 0.9 index

IgM: < 0.9 index

  

IgM antibodies are detectable two weeks after exposure. IgG antibody production usually occurs 18 to 24 days after exposure. The presence of IgM antibodies to parvovirus B19 provides definite evidence of recent infection.

Billing

  
86747 x 2
  
Result 5273-8

Tracking

  
04/10/2019
  
05/20/2019